ESCOZUL™: ITS ORIGIN, HISTORY AND EVOLUTION
FROM ESCOZUL™ TO LIFESCOZUL™
WHO DISCOVERED ESCOZUL™?
WHO WAS MISAEL BORDIER?
STATE PERIOD: LABIOFAM
WHO IS THE GREATEST SCIENTIFIC EXPERT ON ESCOZUL™?
Almost 40 years have passed since the term Escozul™ became popular in the 1980s. In this article we will explain how Escozul™ emerged, who discovered it, and how has the topic evolved over the years.
HOW WAS THE TERM ESCOZUL™ CREAATED AND WHO DISCOVERED IT?
The term Escozul™ emerged in the 1980s and was coined by the late biologist Misael Bordier, who performed basic initial work to demonstrate the antitumor effect of Blue Scorpion Venom.
The reason Misael Bordier decided to experiment with Blue Scorpion's Venom is unclear, but it seems to have been based on the personal experiences of a Haitian shaman.
The name Escozul™ comes from joining two words: “Esco” for the word Escorpion (Spanish for scorpion) and “zul” for the word Azul (Spanish for blue). And although the scorpion from which the name Blue Scorpion Venom comes from has nothing blue except the last part of the tail, it was the word Escozul™ that was best accepted.
Unfortunately, biologist Misael Bordier had many technical and professional limitations, including:
- Not a single scientific publication about his work.
- His patent expired due to lack of scientific evidence.
- He could not isolate the active substance.
- His method never considered the importance of calculating the concentration of the active substance, and therefore the results obtained in patients were very variable.
Regarding Misael Bordier’s method, we must clarify that it was not effective since it tended to degrade the active substance because it was neither purified nor did it use preservatives. Nor could they determine the protein concentration, making the method unfunctional and unfeasible to be sent to other countries outside Cuba.
In 2005 Misael Bordier died without publishing a scientific study in almost 25 years. In his last years his work focused on serving people with handmade treatments, obtaining mixed results.
However, none of this detracts from the importance of Misael Bordier and his team in pioneering the properties of Blue Scorpion Venom and observing results that could lead to a product with an impact on the fight against cancer. Unfortunately, the time limitations made it impossible for Bordier to develop a result beyond the empirical and handmade.
STATE PERIOD 2003-2007: LABIOFAM
After 15 years, the Cuban government, through LABIOFAM, decided to start studying the properties of Blue Scorpion Venom to determine if it actually had antitumor effects.
Between 2003 and 2011 LABIOFAM, through a group of scientific researchers, demonstrated some of the properties of Blue Scorpion Venom in published scientific studies. The highlight was at the 2005 Guantanamo Toxicology event, where conclusive results on these properties were presented.
However, in 2011 LABIOFAM’s management chose to discontinue working with concentrated doses of Blue Scorpion Venom and move on to work with a homeopathic variant called Vidatox 30CH, which from the very beginning was strongly rejected in the Cuban scientific community due to lack of evidence for its use on cancer.
The reason for LABIOFAM's change was basically economic, since producing a natural formula and registering it would have been a long and expensive process, whereas a homeopathic formula does not require clinical trials or scientific evidence and its cost of production is very low.
In 2017, a study was conducted by an Italian University that showed that Vidatox 30CH not only has no presence or trace of Blue Scorpion Venom , but also because of its high degree of alcohol it induces metastasis, making it an unviable product to treat cancer.
The importance of LABIOFAM at this stage is that it was possible to show that Blue Scorpion Venom had a cocktail of antitumor active substances, whose concentration was fundamental in the results. It is also the period where the most results were obtained in patients.
The controversial decision to produce a homeopathic variant had a positive side, as it gave way to the creation of the Grupo LifEscozul™ formed by scientists who worked at LABIOFAM who decided not to continue because they did not agree with the homeopathic variant, thus founding their own Biomedical Research company.
HOW DID GRUPO LIFESCOZUL™ EMERGED AND WHAT IS ITS UNIQUE FORMULATION FOR TREATING CANCER?
Over the years, other scientists joined such as Dr. Alexis Díaz, the highest scientific authority on Blue Scorpion Venom, and Dr. Mariela Guevara, specialist in clinical trials, among other specialists.
Grupo LifEscozul™ is made up of a highly qualified team that includes biologists, biochemists, nutritionists, oncologists, and is characterized by its humanistic and very professional treatment of cancer patients.
To date, it has presented over 3,000 clinical results in patients with one formula: LifEscozul™, which is in the process of obtaining Health Registration.
LifEscozul™ is a formula based on the scientific method and reflects over 17 years of research experience to create a personalized treatment according to the patient's state, with personalized medical follow-up, with doses that are adjusted in each cycle and with biosafety models that guarantee the patient the toxicological safety necessary to be consumed orally.
Among the achievements of the Grupo LifEscozul™ include:
- Personalized health care.
- Unique formulation by type of cancer and patient.
- Periodic checkups.
- 3,000+ reported clinical cases with positive results.
- Determination of the protein concentration of the used samples.
- Processing of samples in level 4 laboratories with FDA authorization.
- Development of patents on active substances.
- Studies on the properties of Blue Scorpion Venom in collaboration with several regional universities.
- Two patents in process.
- Purification and synthesis of the active substances of Blue Scorpion Venom.
- Scientific publications, the latest in: Frontier Farmacology.
We are the only company that continues to study the medical properties of Blue Scorpion Venom, and are currently conducting research on the synthesis of the active substances in Blue Scorpion Venom, for example our studies related to clinical trials.
Our LifEscozul™ formula is in the process of being patented and is ready to begin the Clinical Trials required by health authorities to obtain the Health Registration, making us the leading company in the world in Results and Research.
WHO IS THE GREATEST SCIENTIFIC EXPERT ON ESCOZUL™?
Our Research and Development Department, led by Dr. Alexis Díaz in coordination with several renowned universities, is responsible for the creation of the patent for the LifEscozul™ formula and the development of a synthetic formula of Blue Scorpion venom.